An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

202322 citationsJournal Articlehybrid Open Access

Authors

David Eldred‐Evans · Imperial College London

Henry Tam · Imperial College Healthcare NHS Trust

Heminder Sokhi · Hillingdon Hospitals NHS Foundation Trust

Anwar R. Padhani · Mount Vernon Hospital

Martin J. Connor · Imperial College Healthcare NHS Trust

Derek Price · Solihull Hospital

Martin Gammon

Abstract

The IP1-PROSTAGRAM study shows that PROSTAGRAM magnetic resonance imaging in men with a prostate-specific antigen level of ≥1.0 ng/ml could be a promising pathway to evaluate in future screening trials.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Urologic and reproductive health conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Urology Oncology

Volume 6, Issue 3, pp. 295-302

DOI: 10.1016/j.euo.2023.03.009

Field-Weighted Citation Impact: 5.60